Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications
Cannabis Law Report
NOVEMBER 24, 2021
It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Tilray is identified in the article as “a Canadian company that sells cannabidiol (CBD) and tetrahydrocannabinol (THC) extracts to approved Australian patients for up to $420 per 25?mL 2021;162:S67–79. Visual Studies.
Let's personalize your content